Synopsis of recent research by authors named "Chuyi Han"
- Chuyi Han's recent research primarily focuses on the development of innovative therapeutic strategies utilizing bioinspired reactive oxygen species (ROS) biocatalysts to enhance immune responses in cancer treatments and regenerative therapies for cranial defects.
- Notable findings include the creation of efficient, robust Pt-based biocatalysts that induce immunogenic cell death, potentially improving the efficacy of immune checkpoint blockade therapy in cancer, and the establishment of a standardized model for investigating suture-regenerative therapies in cranial defect restoration.
- Additionally, Han has explored the implications of thyroid hormone levels on clinical outcomes in acute coronary syndrome patients, as well as the effects of PCSK9 inhibitors on lipid metabolism, indicating a diverse research portfolio extending into cardiovascular health and disease management.